# IBANDRONATE SODIUM
> **ANDA202671** · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2014-09-02
## Drug
- **FDA Application Number:** ANDA202671
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IBANDRONATE SODIUM
- **Generic name:** IBANDRONATE SODIUM
- **Active ingredients:** IBANDRONATE SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** PHARMOBEDIENT
- **Manufacturer:** Mylan Institutional LLC
- **First approval:** 2014-09-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202671)
---
*MORVS · CC0 1.0*